Company: JL
Filing Date: 2025-07-28
Form Type: 20-F
Source: 0001213900-25-068049
Chunk: 60

Company: J-Long Group Ltd
Filing Date: 2025-07-28
Form: 20-F
Item: Item 3
Chunk 60
---
 United States subject to the reporting requirements of the Securities Exchange Act
of 1934 (the “ Exchange Act”), the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Nasdaq Global
Market. Section 404 of the Sarbanes-Oxley Act, or Section 404, requires us to include a report from management on the effectiveness
of our internal control over financial reporting in our annual report on Form 20-F beginning with our Annual Report for the fiscal
year ended March 31, 2025. In addition, once we cease to be an “emerging growth company” as such term is defined in
the JOBS Act, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control
over financial reporting. Our management has concluded that our internal control over financial reporting is not effective. Moreover,
even if our management concludes in the future that our internal control over financial reporting is effective, our independent registered
public accounting firm, after conducting its own independent testing, may issue an adverse report if it is not satisfied with our internal
control or the level at which our control is documented, designed, operated or reviewed, or if it interprets relevant requirements differently
from us.

In
addition, our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter
how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will
be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements
due to error or fraud will not occur or that all control issues and instances of fraud will be detected.

If
we fail to comply with the applicable listing standards and Nasdaq delists our Ordinary Shares, we and our shareholders could face significant
material adverse consequences, including :

  limited                                                     

  reduced                             

  a                                                                                                                                 

  a                                                                

  a                                                                                                                            
  decreased ability for us to issue additional equity securities or obtain additional equity or debt financing in the future.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

The
U. S. National Securities Markets Improvement Act of 1996 prevents or pre-empts the states from regulating the sale of
certain securities, which are referred to as “covered securities.” Because our Ordinary Shares are listed on the Nasdaq Global
Market, such securities are covered securities.